Plasma adropin level in patients with pseudoexfoliation
 
Yazarlar (4)
Prof. Dr. Tevfik Oğurel Kırıkkale Üniversitesi, Türkiye
Reyhan Oğurel
Kırıkkale Üniversitesi, Türkiye
Prof. Dr. Nurgül Örnek Kırıkkale Üniversitesi, Türkiye
Prof. Dr. Kemal ÖRNEK Kırıkkale Üniversitesi, Türkiye
Makale Türü Özgün Makale (SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale)
Dergi Adı International Ophthalmology (Q4)
Dergi ISSN 0165-5701 Dergi Bilgileri (2016)
Dergi Tarandığı Indeksler SCI-Expanded
Makale Dili İngilizce Basım Tarihi 01-2016
Cilt / Sayı / Sayfa 36 / 5 / 737–742 DOI 10.1007/s10792-016-0185-8
UAK Araştırma Alanları
Göz Hastalıkları
Özet
The aim of this study was to evaluate plasma adropin levels in patients with pseudoexfoliation (PEX). This retrospective case–control study included 35 patients with PEX and 35 individuals without PEX who served as controls. Plasma adropin levels with triglycerides, total cholesterol, low-density lipoprotein (LDL), high-density lipoprotein (HDL), and haemoglobin A1c (HGBA1C) concentrations were measured in both groups. The mean serum adropin levels were 3.24 ± 0.95 ng/mL (range, 1.90–7.88 ng/mL) in patients with PEX syndrome and 5.78 ± 2.85 ng/mL (range, 2.08–5.41 ng/mL) in PEX glaucoma patients. There was no statistically significant difference in mean adropin levels between PEX syndrome and PEX glaucoma patients. However, similar adropin levels were found in the PEX glaucoma patients and the control group (P > 0.05). The mean serum adropin levels were 3.34 ± 0.89 ng/mL (range, 1.90–5.39 …
Anahtar Kelimeler
Adropin | Glaucoma | Pseudoexfoliation syndrome
BM Sürdürülebilir Kalkınma Amaçları
Atıf Sayıları
Web of Science 5
Scopus 5
Google Scholar 9
Plasma adropin level in patients with pseudoexfoliation

Paylaş